New imaging agent could sharpen prostate cancer detection
NCT ID NCT07162779
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study tests a new radioactive imaging agent, [68Ga]DOTA-IR-780-C-4, to see how well it finds prostate cancer tumors and their spread using PET scans. It involves 5 men with confirmed prostate cancer who have no standard treatment options left. The goal is to improve early and accurate diagnosis, which can help guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PET / CT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jiangnan University Affiliated Hospital
Wuxi, Jiangsu, 214026, China
Conditions
Explore the condition pages connected to this study.